nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—CYP1A2—chronic obstructive pulmonary disease	0.22	0.542	CbGaD
Bromocriptine—HTR2A—chronic obstructive pulmonary disease	0.185	0.458	CbGaD
Bromocriptine—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.107	0.288	CbGbCtD
Bromocriptine—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0814	0.219	CbGbCtD
Bromocriptine—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0814	0.219	CbGbCtD
Bromocriptine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0214	0.0575	CbGbCtD
Bromocriptine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0174	0.0467	CbGbCtD
Bromocriptine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0118	0.0316	CbGbCtD
Bromocriptine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0112	0.0301	CbGbCtD
Bromocriptine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00999	0.0268	CbGbCtD
Bromocriptine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00979	0.0263	CbGbCtD
Bromocriptine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00924	0.0248	CbGbCtD
Bromocriptine—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00599	0.259	CbGeAlD
Bromocriptine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00586	0.0157	CbGbCtD
Bromocriptine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00554	0.0149	CbGbCtD
Bromocriptine—HTR7—pulmonary artery—chronic obstructive pulmonary disease	0.00349	0.151	CbGeAlD
Bromocriptine—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00218	0.0941	CbGeAlD
Bromocriptine—Methylergometrine—HTR2A—chronic obstructive pulmonary disease	0.000702	0.308	CrCbGaD
Bromocriptine—HTR1D—connective tissue—chronic obstructive pulmonary disease	0.000649	0.0281	CbGeAlD
Bromocriptine—ADRB1—connective tissue—chronic obstructive pulmonary disease	0.00063	0.0273	CbGeAlD
Bromocriptine—ADRB1—bronchus—chronic obstructive pulmonary disease	0.000589	0.0255	CbGeAlD
Bromocriptine—HTR7—respiratory system—chronic obstructive pulmonary disease	0.000587	0.0254	CbGeAlD
Bromocriptine—Methysergide—HTR2A—chronic obstructive pulmonary disease	0.000585	0.257	CrCbGaD
Bromocriptine—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000555	0.024	CbGeAlD
Bromocriptine—HTR2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.000552	0.0239	CbGeAlD
Bromocriptine—Ergotamine—CYP1A2—chronic obstructive pulmonary disease	0.000536	0.235	CrCbGaD
Bromocriptine—HTR7—connective tissue—chronic obstructive pulmonary disease	0.000517	0.0224	CbGeAlD
Bromocriptine—HTR7—smooth muscle tissue—chronic obstructive pulmonary disease	0.000473	0.0204	CbGeAlD
Bromocriptine—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000468	0.0203	CbGeAlD
Bromocriptine—Ergotamine—HTR2A—chronic obstructive pulmonary disease	0.000452	0.199	CrCbGaD
Bromocriptine—ADRA2C—bronchus—chronic obstructive pulmonary disease	0.000444	0.0192	CbGeAlD
Bromocriptine—HTR7—trachea—chronic obstructive pulmonary disease	0.000434	0.0188	CbGeAlD
Bromocriptine—ADRA2C—trachea—chronic obstructive pulmonary disease	0.000399	0.0172	CbGeAlD
Bromocriptine—ADRB1—lung—chronic obstructive pulmonary disease	0.00038	0.0164	CbGeAlD
Bromocriptine—ADRA2A—connective tissue—chronic obstructive pulmonary disease	0.000379	0.0164	CbGeAlD
Bromocriptine—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000366	0.0158	CbGeAlD
Bromocriptine—HTR2B—lung—chronic obstructive pulmonary disease	0.000364	0.0157	CbGeAlD
Bromocriptine—ADRA2A—bronchus—chronic obstructive pulmonary disease	0.000354	0.0153	CbGeAlD
Bromocriptine—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000322	0.0139	CbGeAlD
Bromocriptine—ADRA2A—trachea—chronic obstructive pulmonary disease	0.000318	0.0138	CbGeAlD
Bromocriptine—HTR7—lung—chronic obstructive pulmonary disease	0.000312	0.0135	CbGeAlD
Bromocriptine—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000295	0.0128	CbGeAlD
Bromocriptine—DRD2—lung—chronic obstructive pulmonary disease	0.000295	0.0127	CbGeAlD
Bromocriptine—ADRA2C—lung—chronic obstructive pulmonary disease	0.000286	0.0124	CbGeAlD
Bromocriptine—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.000283	0.00238	CcSEcCtD
Bromocriptine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000281	0.00237	CcSEcCtD
Bromocriptine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000281	0.00237	CcSEcCtD
Bromocriptine—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.00236	CcSEcCtD
Bromocriptine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00028	0.00236	CcSEcCtD
Bromocriptine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00028	0.00236	CcSEcCtD
Bromocriptine—Tension—Formoterol—chronic obstructive pulmonary disease	0.00028	0.00236	CcSEcCtD
Bromocriptine—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000279	0.00235	CcSEcCtD
Bromocriptine—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000279	0.00235	CcSEcCtD
Bromocriptine—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00235	CcSEcCtD
Bromocriptine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000277	0.00233	CcSEcCtD
Bromocriptine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000277	0.00233	CcSEcCtD
Bromocriptine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000276	0.00233	CcSEcCtD
Bromocriptine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000276	0.00233	CcSEcCtD
Bromocriptine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.00231	CcSEcCtD
Bromocriptine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000274	0.00231	CcSEcCtD
Bromocriptine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000272	0.00229	CcSEcCtD
Bromocriptine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.00228	CcSEcCtD
Bromocriptine—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000271	0.00228	CcSEcCtD
Bromocriptine—HTR2A—trachea—chronic obstructive pulmonary disease	0.00027	0.0117	CbGeAlD
Bromocriptine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000269	0.00227	CcSEcCtD
Bromocriptine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000268	0.00226	CcSEcCtD
Bromocriptine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000266	0.00224	CcSEcCtD
Bromocriptine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000264	0.00223	CcSEcCtD
Bromocriptine—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000264	0.00222	CcSEcCtD
Bromocriptine—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.000263	0.00222	CcSEcCtD
Bromocriptine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000262	0.00221	CcSEcCtD
Bromocriptine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.00221	CcSEcCtD
Bromocriptine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000261	0.0022	CcSEcCtD
Bromocriptine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000261	0.0022	CcSEcCtD
Bromocriptine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000259	0.00218	CcSEcCtD
Bromocriptine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00218	CcSEcCtD
Bromocriptine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000257	0.00216	CcSEcCtD
Bromocriptine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000254	0.00214	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00025	0.00211	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000249	0.0021	CcSEcCtD
Bromocriptine—CYP1A2—lung—chronic obstructive pulmonary disease	0.000249	0.0108	CbGeAlD
Bromocriptine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.00208	CcSEcCtD
Bromocriptine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000247	0.00208	CcSEcCtD
Bromocriptine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000246	0.00207	CcSEcCtD
Bromocriptine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000246	0.00207	CcSEcCtD
Bromocriptine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000243	0.00205	CcSEcCtD
Bromocriptine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000242	0.00204	CcSEcCtD
Bromocriptine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000242	0.00204	CcSEcCtD
Bromocriptine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000242	0.00204	CcSEcCtD
Bromocriptine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.00204	CcSEcCtD
Bromocriptine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000242	0.00204	CcSEcCtD
Bromocriptine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000242	0.00204	CcSEcCtD
Bromocriptine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000241	0.00203	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000241	0.00203	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000241	0.00203	CcSEcCtD
Bromocriptine—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.00024	0.0104	CbGeAlD
Bromocriptine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000237	0.002	CcSEcCtD
Bromocriptine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000237	0.002	CcSEcCtD
Bromocriptine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000237	0.002	CcSEcCtD
Bromocriptine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.00199	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000236	0.00199	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000236	0.00199	CcSEcCtD
Bromocriptine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000233	0.00196	CcSEcCtD
Bromocriptine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000233	0.00196	CcSEcCtD
Bromocriptine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.00196	CcSEcCtD
Bromocriptine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000231	0.00195	CcSEcCtD
Bromocriptine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000231	0.00195	CcSEcCtD
Bromocriptine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000229	0.00193	CcSEcCtD
Bromocriptine—ADRA2A—lung—chronic obstructive pulmonary disease	0.000229	0.00989	CbGeAlD
Bromocriptine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000228	0.00192	CcSEcCtD
Bromocriptine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000228	0.00192	CcSEcCtD
Bromocriptine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000228	0.00192	CcSEcCtD
Bromocriptine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000228	0.00192	CcSEcCtD
Bromocriptine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000228	0.00192	CcSEcCtD
Bromocriptine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.00191	CcSEcCtD
Bromocriptine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000227	0.00191	CcSEcCtD
Bromocriptine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000226	0.00191	CcSEcCtD
Bromocriptine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.0019	CcSEcCtD
Bromocriptine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000226	0.0019	CcSEcCtD
Bromocriptine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000224	0.00189	CcSEcCtD
Bromocriptine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000223	0.00188	CcSEcCtD
Bromocriptine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000221	0.00186	CcSEcCtD
Bromocriptine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00022	0.00185	CcSEcCtD
Bromocriptine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000218	0.00184	CcSEcCtD
Bromocriptine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000217	0.00183	CcSEcCtD
Bromocriptine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.00183	CcSEcCtD
Bromocriptine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000216	0.00182	CcSEcCtD
Bromocriptine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.00182	CcSEcCtD
Bromocriptine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.00181	CcSEcCtD
Bromocriptine—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000214	0.0018	CcSEcCtD
Bromocriptine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.0018	CcSEcCtD
Bromocriptine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00021	0.00177	CcSEcCtD
Bromocriptine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00021	0.00177	CcSEcCtD
Bromocriptine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.00176	CcSEcCtD
Bromocriptine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000209	0.00176	CcSEcCtD
Bromocriptine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000207	0.00175	CcSEcCtD
Bromocriptine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000207	0.00175	CcSEcCtD
Bromocriptine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000207	0.00174	CcSEcCtD
Bromocriptine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000207	0.00174	CcSEcCtD
Bromocriptine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000206	0.00174	CcSEcCtD
Bromocriptine—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000205	0.00173	CcSEcCtD
Bromocriptine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.00173	CcSEcCtD
Bromocriptine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000205	0.00173	CcSEcCtD
Bromocriptine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.00173	CcSEcCtD
Bromocriptine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000205	0.00172	CcSEcCtD
Bromocriptine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000203	0.00171	CcSEcCtD
Bromocriptine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000202	0.0017	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00169	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00169	CcSEcCtD
Bromocriptine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000201	0.00169	CcSEcCtD
Bromocriptine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00169	CcSEcCtD
Bromocriptine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00169	CcSEcCtD
Bromocriptine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000199	0.00168	CcSEcCtD
Bromocriptine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000199	0.00168	CcSEcCtD
Bromocriptine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00167	CcSEcCtD
Bromocriptine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.00166	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000197	0.00166	CcSEcCtD
Bromocriptine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00166	CcSEcCtD
Bromocriptine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.00165	CcSEcCtD
Bromocriptine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00165	CcSEcCtD
Bromocriptine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000195	0.00164	CcSEcCtD
Bromocriptine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000194	0.00164	CcSEcCtD
Bromocriptine—HTR2A—lung—chronic obstructive pulmonary disease	0.000194	0.00841	CbGeAlD
Bromocriptine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.00163	CcSEcCtD
Bromocriptine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.00163	CcSEcCtD
Bromocriptine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000193	0.00162	CcSEcCtD
Bromocriptine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000193	0.00162	CcSEcCtD
Bromocriptine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000192	0.00162	CcSEcCtD
Bromocriptine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000192	0.00162	CcSEcCtD
Bromocriptine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000191	0.00161	CcSEcCtD
Bromocriptine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.00161	CcSEcCtD
Bromocriptine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000191	0.00161	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00019	0.0016	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00019	0.0016	CcSEcCtD
Bromocriptine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.00019	0.0016	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.0016	CcSEcCtD
Bromocriptine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.0016	CcSEcCtD
Bromocriptine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.00158	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000186	0.00157	CcSEcCtD
Bromocriptine—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000186	0.00157	CcSEcCtD
Bromocriptine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000185	0.00156	CcSEcCtD
Bromocriptine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000185	0.00156	CcSEcCtD
Bromocriptine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000184	0.00155	CcSEcCtD
Bromocriptine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.00155	CcSEcCtD
Bromocriptine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.00155	CcSEcCtD
Bromocriptine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000184	0.00155	CcSEcCtD
Bromocriptine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000183	0.00154	CcSEcCtD
Bromocriptine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000182	0.00153	CcSEcCtD
Bromocriptine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000182	0.00153	CcSEcCtD
Bromocriptine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000182	0.00153	CcSEcCtD
Bromocriptine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000182	0.00153	CcSEcCtD
Bromocriptine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000181	0.00153	CcSEcCtD
Bromocriptine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.00153	CcSEcCtD
Bromocriptine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000181	0.00152	CcSEcCtD
Bromocriptine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000181	0.00152	CcSEcCtD
Bromocriptine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00018	0.00152	CcSEcCtD
Bromocriptine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00018	0.00152	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.00151	CcSEcCtD
Bromocriptine—ABCB1—trachea—chronic obstructive pulmonary disease	0.000177	0.00767	CbGeAlD
Bromocriptine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.00147	CcSEcCtD
Bromocriptine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00146	CcSEcCtD
Bromocriptine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00146	CcSEcCtD
Bromocriptine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000171	0.00144	CcSEcCtD
Bromocriptine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000171	0.00144	CcSEcCtD
Bromocriptine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00141	CcSEcCtD
Bromocriptine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00141	CcSEcCtD
Bromocriptine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000163	0.00138	CcSEcCtD
Bromocriptine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000159	0.00134	CcSEcCtD
Bromocriptine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.00134	CcSEcCtD
Bromocriptine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000158	0.00133	CcSEcCtD
Bromocriptine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00133	CcSEcCtD
Bromocriptine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000156	0.00131	CcSEcCtD
Bromocriptine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000154	0.0013	CcSEcCtD
Bromocriptine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.0013	CcSEcCtD
Bromocriptine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000151	0.00127	CcSEcCtD
Bromocriptine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.00127	CcSEcCtD
Bromocriptine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000148	0.00125	CcSEcCtD
Bromocriptine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.00125	CcSEcCtD
Bromocriptine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000147	0.00124	CcSEcCtD
Bromocriptine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.00124	CcSEcCtD
Bromocriptine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000147	0.00123	CcSEcCtD
Bromocriptine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.00123	CcSEcCtD
Bromocriptine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000146	0.00123	CcSEcCtD
Bromocriptine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.00123	CcSEcCtD
Bromocriptine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000145	0.00123	CcSEcCtD
Bromocriptine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.00122	CcSEcCtD
Bromocriptine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000145	0.00122	CcSEcCtD
Bromocriptine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000144	0.00121	CcSEcCtD
Bromocriptine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000144	0.00121	CcSEcCtD
Bromocriptine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000143	0.0012	CcSEcCtD
Bromocriptine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00119	CcSEcCtD
Bromocriptine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000141	0.00119	CcSEcCtD
Bromocriptine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.00118	CcSEcCtD
Bromocriptine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.00117	CcSEcCtD
Bromocriptine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.00117	CcSEcCtD
Bromocriptine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000138	0.00117	CcSEcCtD
Bromocriptine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.00117	CcSEcCtD
Bromocriptine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000138	0.00116	CcSEcCtD
Bromocriptine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000138	0.00116	CcSEcCtD
Bromocriptine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.00116	CcSEcCtD
Bromocriptine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.00114	CcSEcCtD
Bromocriptine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000135	0.00114	CcSEcCtD
Bromocriptine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.00113	CcSEcCtD
Bromocriptine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.00112	CcSEcCtD
Bromocriptine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00111	CcSEcCtD
Bromocriptine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.0011	CcSEcCtD
Bromocriptine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000128	0.00108	CcSEcCtD
Bromocriptine—ABCB1—lung—chronic obstructive pulmonary disease	0.000127	0.00551	CbGeAlD
Bromocriptine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00107	CcSEcCtD
Bromocriptine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.00106	CcSEcCtD
Bromocriptine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000124	0.00104	CcSEcCtD
Bromocriptine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.00104	CcSEcCtD
Bromocriptine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.00012	0.00101	CcSEcCtD
Bromocriptine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000985	CcSEcCtD
Bromocriptine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000115	0.00097	CcSEcCtD
Bromocriptine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.00096	CcSEcCtD
Bromocriptine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000959	CcSEcCtD
Bromocriptine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000953	CcSEcCtD
Bromocriptine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000951	CcSEcCtD
Bromocriptine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000891	CcSEcCtD
Bromocriptine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000875	CcSEcCtD
Bromocriptine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000869	CcSEcCtD
Bromocriptine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000849	CcSEcCtD
Bromocriptine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000848	CcSEcCtD
Bromocriptine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.0001	0.000843	CcSEcCtD
Bromocriptine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	9.86e-05	0.000831	CcSEcCtD
Bromocriptine—Convulsion—Prednisone—chronic obstructive pulmonary disease	9.72e-05	0.000819	CcSEcCtD
Bromocriptine—Hypertension—Prednisone—chronic obstructive pulmonary disease	9.69e-05	0.000816	CcSEcCtD
Bromocriptine—Anxiety—Prednisone—chronic obstructive pulmonary disease	9.52e-05	0.000802	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	9.48e-05	0.000799	CcSEcCtD
Bromocriptine—Oedema—Prednisone—chronic obstructive pulmonary disease	9.16e-05	0.000771	CcSEcCtD
Bromocriptine—Infection—Prednisone—chronic obstructive pulmonary disease	9.1e-05	0.000766	CcSEcCtD
Bromocriptine—Shock—Prednisone—chronic obstructive pulmonary disease	9.01e-05	0.000759	CcSEcCtD
Bromocriptine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	8.98e-05	0.000757	CcSEcCtD
Bromocriptine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	8.94e-05	0.000753	CcSEcCtD
Bromocriptine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	8.89e-05	0.000749	CcSEcCtD
Bromocriptine—Anorexia—Prednisone—chronic obstructive pulmonary disease	8.73e-05	0.000735	CcSEcCtD
Bromocriptine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	8.33e-05	0.000702	CcSEcCtD
Bromocriptine—Insomnia—Prednisone—chronic obstructive pulmonary disease	8.28e-05	0.000698	CcSEcCtD
Bromocriptine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	8.22e-05	0.000693	CcSEcCtD
Bromocriptine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	8.06e-05	0.000679	CcSEcCtD
Bromocriptine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	7.96e-05	0.000671	CcSEcCtD
Bromocriptine—Rash—Prednisolone—chronic obstructive pulmonary disease	7.94e-05	0.000669	CcSEcCtD
Bromocriptine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	7.94e-05	0.000669	CcSEcCtD
Bromocriptine—Fatigue—Prednisone—chronic obstructive pulmonary disease	7.89e-05	0.000665	CcSEcCtD
Bromocriptine—Headache—Prednisolone—chronic obstructive pulmonary disease	7.89e-05	0.000665	CcSEcCtD
Bromocriptine—Constipation—Prednisone—chronic obstructive pulmonary disease	7.83e-05	0.00066	CcSEcCtD
Bromocriptine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	7.54e-05	0.000636	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	7.49e-05	0.000631	CcSEcCtD
Bromocriptine—Nausea—Prednisolone—chronic obstructive pulmonary disease	7.48e-05	0.000631	CcSEcCtD
Bromocriptine—Urticaria—Prednisone—chronic obstructive pulmonary disease	7.27e-05	0.000613	CcSEcCtD
Bromocriptine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	7.24e-05	0.00061	CcSEcCtD
Bromocriptine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	7.24e-05	0.00061	CcSEcCtD
Bromocriptine—Asthenia—Prednisone—chronic obstructive pulmonary disease	6.57e-05	0.000553	CcSEcCtD
Bromocriptine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	6.26e-05	0.000528	CcSEcCtD
Bromocriptine—Dizziness—Prednisone—chronic obstructive pulmonary disease	6.05e-05	0.00051	CcSEcCtD
Bromocriptine—Vomiting—Prednisone—chronic obstructive pulmonary disease	5.82e-05	0.00049	CcSEcCtD
Bromocriptine—Rash—Prednisone—chronic obstructive pulmonary disease	5.77e-05	0.000486	CcSEcCtD
Bromocriptine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	5.77e-05	0.000486	CcSEcCtD
Bromocriptine—Headache—Prednisone—chronic obstructive pulmonary disease	5.74e-05	0.000483	CcSEcCtD
Bromocriptine—Nausea—Prednisone—chronic obstructive pulmonary disease	5.44e-05	0.000458	CcSEcCtD
Bromocriptine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.63e-06	8.46e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.62e-06	8.43e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.59e-06	8.4e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.58e-06	8.38e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	6.56e-06	8.36e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.52e-06	8.31e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.51e-06	8.3e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.48e-06	8.26e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.48e-06	8.26e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.48e-06	8.26e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.48e-06	8.25e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.47e-06	8.25e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.41e-06	8.17e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.38e-06	8.13e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.38e-06	8.13e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	6.34e-06	8.07e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.33e-06	8.07e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.33e-06	8.07e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.33e-06	8.07e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.32e-06	8.06e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.32e-06	8.06e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.19e-06	7.89e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.11e-06	7.79e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.11e-06	7.79e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.1e-06	7.77e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—ALB—chronic obstructive pulmonary disease	6.07e-06	7.74e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.03e-06	7.69e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.03e-06	7.69e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.02e-06	7.67e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.01e-06	7.66e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.98e-06	7.63e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.97e-06	7.61e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.92e-06	7.55e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.89e-06	7.5e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.88e-06	7.5e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.85e-06	7.45e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.84e-06	7.44e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.81e-06	7.4e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—NOS3—chronic obstructive pulmonary disease	5.81e-06	7.4e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.79e-06	7.38e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.76e-06	7.34e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.76e-06	7.34e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.76e-06	7.34e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.76e-06	7.34e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.75e-06	7.33e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.72e-06	7.29e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.71e-06	7.28e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.71e-06	7.27e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.7e-06	7.26e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.68e-06	7.24e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.68e-06	7.23e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.67e-06	7.22e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.66e-06	7.22e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.56e-06	7.08e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.51e-06	7.02e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.5e-06	7.01e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.49e-06	7e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.48e-06	6.99e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.47e-06	6.97e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.45e-06	6.94e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.44e-06	6.93e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.43e-06	6.93e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.4e-06	6.88e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.33e-06	6.79e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.29e-06	6.75e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.29e-06	6.74e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.27e-06	6.71e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.26e-06	6.7e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.25e-06	6.69e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.25e-06	6.69e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.23e-06	6.67e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.22e-06	6.65e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.2e-06	6.63e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.2e-06	6.63e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.18e-06	6.6e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.12e-06	6.53e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.11e-06	6.51e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.11e-06	6.51e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.09e-06	6.48e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	5.06e-06	6.45e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.02e-06	6.4e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.02e-06	6.4e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.01e-06	6.38e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.99e-06	6.36e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.97e-06	6.33e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	4.93e-06	6.29e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.92e-06	6.28e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.89e-06	6.23e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.88e-06	6.22e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.86e-06	6.19e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.86e-06	6.19e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.86e-06	6.19e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.85e-06	6.18e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.84e-06	6.16e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.78e-06	6.1e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.78e-06	6.09e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.76e-06	6.07e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.75e-06	6.05e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	4.72e-06	6.01e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.68e-06	5.97e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.67e-06	5.95e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.66e-06	5.94e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.66e-06	5.93e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.62e-06	5.89e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.62e-06	5.89e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.62e-06	5.89e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.62e-06	5.88e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.61e-06	5.88e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.6e-06	5.86e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.54e-06	5.79e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.54e-06	5.78e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.48e-06	5.72e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.48e-06	5.71e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.46e-06	5.68e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.45e-06	5.67e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.45e-06	5.67e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.45e-06	5.67e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.43e-06	5.65e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.43e-06	5.64e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.41e-06	5.62e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.4e-06	5.6e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.39e-06	5.6e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.39e-06	5.59e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.38e-06	5.58e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.36e-06	5.56e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.36e-06	5.55e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.34e-06	5.53e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.33e-06	5.52e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.31e-06	5.49e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.29e-06	5.46e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.27e-06	5.44e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.26e-06	5.42e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.25e-06	5.41e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.24e-06	5.4e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.23e-06	5.4e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.23e-06	5.39e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.21e-06	5.37e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.21e-06	5.37e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.21e-06	5.36e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.2e-06	5.36e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.17e-06	5.32e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.15e-06	5.29e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.15e-06	5.29e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.13e-06	5.27e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.1e-06	5.22e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.09e-06	5.22e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.03e-06	5.14e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.03e-06	5.13e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.01e-06	5.11e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.01e-06	5.11e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.01e-06	5.11e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.95e-06	5.03e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.91e-06	4.98e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.9e-06	4.97e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.86e-06	4.92e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.85e-06	4.9e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.84e-06	4.89e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.81e-06	4.85e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.81e-06	4.85e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.78e-06	4.82e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.78e-06	4.82e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.77e-06	4.8e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.75e-06	4.77e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.73e-06	4.76e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.73e-06	4.76e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.72e-06	4.74e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.69e-06	4.7e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.69e-06	4.7e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.66e-06	4.67e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.66e-06	4.66e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.62e-06	4.61e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.6e-06	4.59e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.59e-06	4.57e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.58e-06	4.56e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.55e-06	4.52e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.54e-06	4.51e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.53e-06	4.5e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.5e-06	4.46e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.5e-06	4.46e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.5e-06	4.46e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.48e-06	4.43e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.47e-06	4.42e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.44e-06	4.39e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.44e-06	4.38e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	3.41e-06	4.35e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.41e-06	4.34e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.4e-06	4.34e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.38e-06	4.31e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.38e-06	4.3e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.37e-06	4.3e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.37e-06	4.29e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.35e-06	4.27e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.33e-06	4.24e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.32e-06	4.23e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.3e-06	4.21e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.28e-06	4.18e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.26e-06	4.16e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.26e-06	4.16e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.25e-06	4.15e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.24e-06	4.13e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.23e-06	4.12e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.21e-06	4.09e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.18e-06	4.05e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.18e-06	4.05e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.17e-06	4.03e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.16e-06	4.03e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.15e-06	4.01e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.14e-06	4e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.14e-06	4e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.12e-06	3.98e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.1e-06	3.95e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.09e-06	3.94e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.08e-06	3.93e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.06e-06	3.9e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.91e-06	3.71e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.91e-06	3.71e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.87e-06	3.66e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.87e-06	3.66e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.87e-06	3.65e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.86e-06	3.64e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.86e-06	3.64e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.84e-06	3.62e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.83e-06	3.61e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.81e-06	3.58e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.81e-06	3.58e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.75e-06	3.51e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.73e-06	3.48e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.72e-06	3.47e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.72e-06	3.46e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.64e-06	3.37e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.62e-06	3.33e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.61e-06	3.32e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.6e-06	3.32e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.6e-06	3.32e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.59e-06	3.3e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.56e-06	3.26e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.5e-06	3.19e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.49e-06	3.17e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.42e-06	3.08e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.4e-06	3.06e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.38e-06	3.04e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.36e-06	3.01e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.31e-06	2.95e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.2e-06	2.8e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.16e-06	2.75e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.15e-06	2.74e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.12e-06	2.7e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.1e-06	2.68e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.01e-06	2.56e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.97e-06	2.51e-05	CbGpPWpGaD
